Fixed
Gap
Market

A massive, underserved market.

Post-stroke rehabilitation is one of the largest unmet needs in digital health — and it is growing.

Go-to-market

From Madrid to the world.

Starting in Spain, expanding to the U.S., Germany, and France — targeting the largest post-stroke rehabilitation markets where remote monitoring is most needed.

Click on a country to see stroke data

Click on a country to see stroke data

The workforce gap

There are not enough neurologists.
There never will be.

The stroke rehabilitation workforce shortage is structural and permanent. Remote monitoring is not a product feature — it is the only scalable solution.

1,015

stroke patients per neurologist in Spanish stroke units

Spain — SEN, October 2025

3,367

stroke patients per dedicated stroke neurologist worldwide

Global — World Federation of Neurology

4,000,000

patients per neurological professional in low-income countries

WHO Atlas 2017 — worst case ratio

Market opportunity

The numbers behind the opportunity.

TAM

$42B

Global neurorehabilitation + digital health technologies

SAM

$8-12B

Post-stroke rehab monitoring in U.S., Germany, France, Spain

SOM (Year 3)

0.5-1%

500-1,000 subscribers or 5,000-15,000 monthly active patients

Why now

Six forces converging at once.

1

Rising stroke prevalence globally

2

Increasing strain on rehabilitation workforces

3

Shift toward digital health and remote care

4

Computer vision now accessible without hardware

5

Value-based care models incentivize outcomes

6

Patients already have cameras on their devices

Business model

B2B SaaS. Simple and scalable.

Hospitals and rehab clinics subscribe. Patients are users, not payers. Value-based contracts as a future phase.

$149-249

per clinician / month

Hospitals and rehab clinics subscribe. The neurologist pays, the patient plays for free.

$45-65

per patient / month

Per-patient contracts with insurers. ROI argument: one prevented readmission saves $3,000-8,000.

Ready to be part of this market?

We are looking for clinical partners, investors, and early adopters.

Get in touch